Skip to main content
Premium Trial:

Request an Annual Quote

Millipore and Proteome Systems to Develop Proteomics Kit

NEW YORK, March 7 – Proteome Systems and Millipore have agreed to develop and market proteomics kits using Millipore’s sample preparation technology and Proteome’s proteomics technology, the companies said Wednesday.

The first kit, to be used for protein digestion in 2D gels prior to performing mass spectrometry analysis, will harness Millipore’s MultiScreen and ZipTip products. Proteome, of Sydney, Australia, will assemble the kits, and Millipore, of Bedford, Mass., will hold the exclusive distribution rights. 

"We expect the first of a series of gel digestion kits to be introduced shortly,” said Keith Williams, CEO of Proteome, in a statement. “The device and membrane expertise of Millipore coupled with our proteomics expertise will lead to novel solutions for proteomics researchers." 

Proteome Systems, with 75 employees in Sydney and Boston, is currently building a large-scale protoemics platform using its instruments, consumables, and informatics technologies. The company expects to release the full platform in the second half of this year.

Proteome has previously signed partnerships with Shimadzu Corporation and its subsidiary Kratos Analytical; Sigma Aldrich; and MicroFab Technologies.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.